Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

NHS adds 125 scanners and AI to speed cancer diagnosis

England’s NHS added 125 CT and MRI scanners and expanded AI imaging, delivering one million extra scans a year for faster cancer diagnosis.

By Dr. Revathy Mohan V.R., MBBS · Nov 3, 2026 · 5 min read

Oncology·NIH

Resveratrol Review Examines Cancer, Regeneration and Bioavailability Limits

A review outlines resveratrol’s anti-cancer and regenerative mechanisms, while stressing its poor absorption, rapid metabolism, and combination-therapy potential.

Nov 3, 2026

Oncology·Nature

Serum sHLA-G shows limited value in endometrial cancer risk stratification

A retrospective study found serum sHLA-G was not elevated in endometrial cancer overall, with only exploratory signals in…

Nov 3, 2026

Oncology·Becker H

Early-Onset Colorectal Cancer in Mexico Linked to Long Diagnostic Delays

A Mexican cohort found early-onset colorectal cancer often reached diagnosis after long delays, with most patients already at…

Nov 3, 2026

Oncology·JCI

Head and Neck Cancer Article Cannot Be Fully Rewritten From Incomplete Source

The scraped source lacks the article body, so no accurate clinical rewrite can be produced without inventing trial…

Nov 3, 2026

Oncology·Dentistry.co.uk

Bioengineered chewing gum cuts HPV and oral cancer-linked bacteria

A lablab bean chewing gum reduced HPV and two oral bacteria tied to head and neck cancer, with…

Nov 3, 2026

Oncology·Nature

Denosumab in multiple myeloma with severe renal impairment lowers CTX but raises hypocalcemia risk

A phase 2 study found denosumab lowered bone resorption in multiple myeloma with CrCl below 30 mL/min, but…

Nov 3, 2026

Oncology·JCI

Therapy-Linked Mutational Signatures Recast Cancer Survivorship Risk

JCI viewpoint examines how chemotherapy and radiation leave genomic scars, shape relapse biology, and may refine long-term survivorship…

Nov 3, 2026

Oncology·JCI

Neuroendocrine Tumor Classification May Shift Toward Cell State Programs

A JCI commentary outlines how conserved neuronal-like and secretory programs could refine neuroendocrine tumor classification and therapy targeting.

Nov 3, 2026

Oncology·JCI

Gastroenteropancreatic Neuroendocrine Tumors Show Conserved Spatial Programs

A JCI study examines how neuronal-like and secretory gene programs shape the spatial architecture of gastroenteropancreatic neuroendocrine tumors.

Nov 3, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.